FDA Inspection 1192553 — Linical Accelovance America, Inc.
The FDA completed an inspection of Linical Accelovance America, Inc. on Nov 17, 2022 in Stuart, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 17, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Stuart, FL (United States)
Additional Details
Sponsor, Contract Research Organization